Accelerating drug discovery with high resolution profiling of the immune system
WHAT IS IMMUNE PROFILER AND HOW DOES IT WORK?
Immune Profiler is a next generation discovery tool leveraging high-resolution immune measurements and advanced analytics to accelerate and enhance biomarker and target discovery by:
Combining cytometry, whole genome sequencing, genetics, transcriptomics, epigenomics, and proteomics in coordination workflows to yield a deep and broad view of immune function.
Integrating high- resolution molecular phenotypes in powerful and efficient analytical workflows optimized to yield insights with translational value.
HOW CAN IMMUNE PROFILER SUPPORT DRUG DISCOVERY?
Immune Profiler provides access to applications in drug discovery that can:
Uncover novel disease mechanisms and pathways
Predict and validate novel drug targets and combinations using primary human data
Identify drug label expansion and repositioning opportunities
Discover biomarkers that can differentiate patient outcomes (e.g. response to treatment or disease progression)
THE LATEST NEWS ON IMMUNE PROFILER
Sosei Heptares and Verily will collaborate to generate novel drug candidates against GPCR targets for immune-mediated diseases
Verily partners with Sosei Heptares to identify drug targets for immune-mediated disease. The agreement combines the complementary technology capabilities of Verily’s next generation immune mapping platform (Immune Profiler) and Sosei Heptares’ G-protein-coupled receptors (GPCR) structure-based drug design.